Roche is a Swiss multinational pharmaceutical and diagnostics company headquartered in Basel, with ~101,000 employees and CHF 62.8B annual revenue (2021).
Is this your business? Add your evidence →
Roche has achieved strong operational decarbonisation (46% S1&2 reduction since 2022) and received SBTi validation for net-zero targets — a pharma first. However, nature and biodiversity assessment remains absent, water targets lack absolute reduction commitments, and significant non-environmental regulatory penalties ($433M since 2000) persist alongside VCI trade association misalignment.
Roche Holding scores 49/100 (Making progress) on SINK's independent climate assessment, scored from public data only. Fees pay for the review, never the result. Last verified May 2026.
That places Roche Holding joint 169th of 847 companies scored, and 7th of 19 in Healthcare / Pharmaceuticals.
Where Roche Holding sits among healthcare / pharmaceuticals peers.
Among the 19 major healthcare / pharmaceuticals brands we've scored, Roche Holding sits 7th of 19.
Its three lowest-scoring questions, and what the evidence didn't show.
However, World Benchmarking Alliance found no biodiversity impact assessment in operations or supply chain, no disclosure of operations near sensitive areas, and no TNFD alignment.
Publicly available quantified circular economy metrics and plastic waste volumes remain limited.
No absolute water reduction targets set; supplier engagement on water absent.
A score changes when the evidence does. We use new published evidence at the next rescore. Evidence that isn't public can count through an evidence review.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Add your evidence, £99
Scored low because little is published? Send us your evidence. A person reviews it and your score reflects what you really do. Done within 5 working days.
Evidence review →Go tender-ready, £495 a year
A yearly rescore, a check of up to 25 key suppliers and a score badge for your website (coming soon).
Get in touch →Strongest on Targets & Commitments and Carbon Footprint — Operations (9/10, 8/10). Weakest on Nature & Biodiversity Impact and Resource Use & Waste (4/10, 5/10).
The 3 companies in the sector scoring nearest above Roche Holding.
Haleon reports comprehensively on Scope 1+2 emissions and has achieved 100% renewable electricity, with verified 55% net reduction versus 2020.
See the breakdown →Novartis demonstrates solid operational decarbonization and supply-chain engagement but relies heavily on carbon credits for claimed neutrality.
See the breakdown →Sanofi has delivered genuine absolute emission reductions (47% Scope 1&2, 10% Scope 3 vs 2019) and SBTi-validated net-zero targets to 2045.
See the breakdown →The formula and all 13 sources.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale13 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
If you believe a source has been misread or a newer version exists, submit a challenge.
Roche is a Swiss multinational pharmaceutical and diagnostics company headquartered in Basel, with ~101,000 employees and CHF 62.8B annual revenue (2021). It operates globally across prescription drugs, diagnostics, and healthcare solutions, ranking among the world's largest pharma companies by market capitalisation.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
See what's behind your number →Fees pay for the review, never the result.